“Decreased BDNF Levels in Amygdala and Hippocampus After Intracerebroventricular Administration of Ouabain”. Archives of Clinical Psychiatry 39, no. 5 (January 1, 2012): 157–160. Accessed May 7, 2024. https://www.revistas.usp.br/acp/article/view/48310.